Evotec SE (EVOTF) Research & Development (2020 - 2025)

Evotec SE's (EVOTF) quarterly Research & Development came in at $43.7 million in Q4 2025, down 19.66% year-on-year from $54.4 million in Q4 2024, and up 429065.53% quarter-over-quarter from -$10186.0 in Q3 2025.

Evotec SE (EVOTF) Research & Development (2020 - 2025) Analysis & Trends

Evotec SE has disclosed Research & Development across 6 years of filings, most recently posting $43.7 million for Q4 2025.

  • Research & Development for Q4 2025 came in at $43.7 million, down 19.66% year-over-year; the trailing twelve-month figure through Dec 2025 was $98.1 million (down 23.5% YoY), and the FY2025 annual result was $43.7 million, down 19.66% from the prior year.
  • Research & Development came in at $43.7 million for Q4 2025 at Evotec SE, up from -$10186.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $82.5 million in Q4 2021 to a low of -$22267.1 in Q1 2021.
  • The 5-year median for Research & Development is $18634.9 (2022), against an average of $22.2 million.
  • Across the five-year window, Research & Development surged 32.55% in 2023 and slumped 168.44% in 2024, its largest moves.
  • Evotec SE's Research & Development stood at $82.5 million in 2021, then fell by 5.33% to $78.1 million in 2022, then slipped by 5.57% to $73.8 million in 2023, then declined by 26.29% to $54.4 million in 2024, then decreased by 19.66% to $43.7 million in 2025.
  • The last three Research & Development figures came in at $43.7 million (Q4 2025), -$10186.0 (Q3 2025), and $54.4 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Evotec SE - - - -

Historic Data

Download Data
DateValue
Dec 31, 2025 43.69 Mn
Sep 30, 2025 -10,185.98
Dec 31, 2024 54.39 Mn
Sep 30, 2024 -13,040.26
Dec 31, 2023 73.79 Mn
Sep 30, 2023 19,053.60
Jun 30, 2023 -13,477.62
Dec 31, 2022 78.14 Mn
Sep 30, 2022 18,634.93
Jun 30, 2022 -19,980.64
Mar 31, 2022 -20,328.90
Dec 31, 2021 82.53 Mn
Sep 30, 2021 21,271.98
Jun 30, 2021 -20,441.30
Mar 31, 2021 -22,267.12
Dec 31, 2020 76.19 Mn
Sep 30, 2020 19,017.47